Partner David Rosen, who chairs the firm’s FDA regulatory practice, was quoted in a Law360 article, “FDA Focus: What Foley & Lardner’s Practice Chair is Watching,” about litigation and regulation he’s watching, the skills he looks for when hiring an FDA lawyer and the one FDA policy he’d change if he had a magic wand.
Rosen said the firm does a lot of work with compliance and enforcement, especially with data integrity issues. He also said he’s always been a “stickler” about making sure products meet appropriate standards of identity, strength, quality and purity at the time of use.
People
Related News
16 May 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.
16 May 2025
In the News
Foley Attorneys Assess AI Use in Clinical Trials
Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"
15 May 2025
In the News
Grace Fucci Publishes on Sustainability in Luxury Fashion
Foley & Lardner LLP associate Grace Fucci explores the intersection of luxury fashion and sustainability in The Global Legal Post article, "Can luxury fashion houses join the sustainability discussion?"